Skip to main content

Table 1 Basline clinicopathologic characteristics of 1360 patients with renal cell carcinoma (RCC) undergoing nephrectomy

From: Prognostic significance of the combination of preoperative hemoglobin and albumin levels and lymphocyte and platelet counts (HALP) in patients with renal cell carcinoma after nephrectomy

Characteristics

Total n = 1360

Age, years, median (IQR)

55 (46–65)

Female sex

408 (30%)

Histology subtype

 ccRCC

1228 (90.29%)

 non-ccRCC

132 (9.71%)

Location

 left

626 (46.03%)

 right

697 (51.25%)

 bilateral

37 (2.72%)

Fuhrman grade

 1

374 (27.5%)

 2

738 (54.26%)

 3

237 (17.43%)

 4

11 (0.81%)

T-stage

 1

1015 (74.63%)

 2

113 (8.32%)

 3

225 (16.54%)

 4

7 (0.51%)

N status

 negative

1327 (97.57%)

 positive

33 (2.43%)

ASA grade

 1

192 (14.12%)

 2

1072 (78.82%)

 3&4

96 (7.06%)

Sarcomatoid transformation

65 (4.78%)

Metastasis

61 (4.48%)

Lymphovascular invasion

100 (7.35%)

Necrosis

419 (3.08%)

Hypoalbuminemia

53 (3.9%)

Anemia

267 (19.6%)

NLR, median (IQR)

2.13 (1.60–2.85)

PLR, median (IQR)

124.07 (97.33–165.22)

HALP, median (IQR)

47.48 (33.21–63.45)

  1. Data are n (%) unless indicated. IQR interquartile ratio, ccRCC clear-cell renal cell carcinoma, ASA American Society of Anesthesiologists, NLR neutrophil-to-lymphocyte ratio, PLR platelet-to-lymphocyte ratio, HALP hemoglobin and albumin levels and lymphocyte and platelet counts